GYRE Insider Trading 2026
Gyre Therapeutics Inc. - Executive & director stock transactions
Net Sentiment
Neutral
Insider Buys
0
Insider Sells
0
Stock Price
$6.45
No recent insider trading activity for GYRE.
Get Full GYRE Analysis
Institutional ownership, financials, and AI insights
View Full AnalysisFrequently Asked Questions
Are insiders buying or selling GYRE?
Recent insider trading data for GYRE is being updated.
What is GYRE insider trading activity?
Check back for the latest GYRE insider trading activity.
Why do insiders buy GYRE stock?
Insiders (executives, directors, major shareholders) may buy GYRE stock because they believe it's undervalued or expect positive developments. Insider buying is often seen as a bullish signal since they have deep knowledge of the company.
Why do insiders sell GYRE stock?
Insiders may sell for various reasons including diversification, personal financial needs, or as part of planned 10b5-1 trading plans. Insider selling doesn't always indicate bearish sentiment - context matters.
What is the net insider activity for GYRE?
Net insider activity data for GYRE will be available when recent transactions are reported.
How do I track GYRE insider trades?
GYRE insider trades are disclosed through SEC Form 4 filings, which must be submitted within 2 business days of the transaction. This page automatically tracks and displays the latest Form 4 filings for Gyre Therapeutics Inc..
What is a 10b5-1 trading plan for GYRE?
A 10b5-1 trading plan allows GYRE insiders to set up predetermined trading schedules when they don't have material non-public information. This protects executives from insider trading accusations while allowing them to diversify holdings.
Is GYRE insider buying a good sign?
GYRE insider buying can be a positive signal since executives know the company intimately. However, context matters - consider the size of purchases relative to their holdings, the number of insiders buying, and whether it's open market purchases versus options exercises.